Micro-gRx was founded to adapt and enhance life sciences disease modeling technologies for use in space.

By integrating stem cell biology and advanced microfluidic technology, the company plans to utilize the unique platform of microgravity which accelerates changes in cell growth similar to what occurs in the aging and disease process of tissues to perform human cell-based assays for disease research and drug efficacy studies.  (Read article)